- $2.83bn
- $2.74bn
- $1.33bn
- 98
- 53
- 86
- 93
2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | 2023 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,161 | 1,081 | 1,145 | 1,302 | 1,332 |
Cost of Revenue | |||||
Gross Profit | 579 | 529 | 561 | 632 | 657 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 998 | 943 | 978 | 1,109 | 1,107 |
Operating Profit | 162 | 138 | 167 | 193 | 225 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 165 | 141 | 171 | 192 | 226 |
Provision for Income Taxes | |||||
Net Income After Taxes | 131 | 113 | 135 | 150 | 175 |
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 131 | 112 | 130 | 150 | 175 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 130 | 112 | 129 | 149 | 174 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.45 | 2.3 | 2.51 | 2.89 | 3.49 |
Dividends per Share |